AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionDDD Partners, LLC
Latest Disclosed Ownership91,397 shares
Latest Disclosed Value $ 19,877,866
DDD Partners, LLC reports 3.11% increase in ownership of 4AB / AbbVie Inc.

On April 28, 2026 - DDD Partners, LLC filed a 13F-HR form disclosing ownership of 91,397 shares of AbbVie Inc. (BG:4AB) valued at $19,877,866 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 88,640 shares of AbbVie Inc.. This represents a change in shares of 3.11% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ABBVIE COM 00287Y109 91,397 2,757 3.11 19,878 -1.86 1.3704
2026-01-22 2025-12-31 13F ABBVIE COM 00287Y109 88,640 234 0.26 20,253 -1.06 1.2890
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 88,406 -18,274 -17.13 20,469 3.37 1.3004
2025-07-31 2025-06-30 13F ABBVIE COM 00287Y109 106,680 -5,843 -5.19 19,802 -16.01 2.1230
2025-05-02 2025-03-31 13F ABBVIE COM 00287Y109 112,523 -12,822 -10.23 23,576 5.85 2.8644
2025-01-31 2024-12-31 13F ABBVIE COM 00287Y109 125,345 11,168 9.78 22,274 -1.22 2.7372
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 114,177 507 0.45 22,548 15.65 2.4483
2024-08-01 2024-06-30 13F ABBVIE COM 00287Y109 113,670 365 0.32 19,497 -5.51 2.2605
2024-05-09 2024-03-31 13F ABBVIE COM 00287Y109 113,305 -19,002 -14.36 20,633 0.63 2.5217
2024-01-18 2023-12-31 13F ABBVIE COM 00287Y109 132,307 -822 -0.62 20,504 3.85 2.7560
2023-10-18 2023-09-30 13F ABBVIE COM 00287Y109 133,129 -2,544 -1.88 19,743 8.01 2.8474
2023-08-02 2023-06-30 13F ABBVIE COM 00287Y109 135,673 134,327 9,979.72 18,279 8,441.59 2.5307
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 1,346 5 0.37 215 -0.93 0.0334
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 1,341 1,341 217 0.0347
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.